20 (AIDX) Non-Current Assets (2024 - 2026)

20 (AIDX) posted Non-Current Assets of $1.1 million for Q1 2026, down 58.63% on a QoQ basis from $2.7 million in Q4 2025.

20 (AIDX) Non-Current Assets (2024 - 2026) Analysis & Trends

20's Non-Current Assets history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	84.92 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	32.95 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	68.24 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	35.67 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	7.09 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	2.30 Bn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	20.47 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	26.70 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	6.35 Bn
10	20	3.91 Mn	-313,912.28	62,884.00	1.10 Mn

Download Data